MRI Radiomics for Assessment of Molecular Subtype, Pathological Complete Response, and Residual Cancer Burden in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy

Cancer Patients ◽

Molecular Subtype ◽

Complete Response ◽

Breast Cancer Patients ◽

Residual Cancer ◽

Cancer Burden ◽

Residual Cancer Burden

Prognostic factors associated with pathological complete response in early breast cancer patients undergoing neoadjuvant chemotherapy: The importance of Ki-67 and molecular subtype

Annals of Oncology ◽

10.1093/annonc/mdy270.230 ◽

2018 ◽

Vol 29 ◽

pp. viii75

Author(s):

B.L. Rapoport ◽

J.A. Barnard-Tidy ◽

T. Smit ◽

S.J. Nayler ◽

C.A. Benn

Keyword(s):

Breast Cancer ◽

Prognostic Factors ◽

Cancer Patients ◽

Molecular Subtype ◽

Complete Response ◽

Breast Cancer Patients ◽

Ki 67 ◽

Factors Associated

Residual cancer burden (RCB) in breast cancer patients treated with taxane- and anthracycline-based neoadjuvant chemotherapy: The effect of race.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.607 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 607-607 ◽

Cited By ~ 2

Author(s):

M. Chavez-Mac Gregor ◽

R. Hubbard ◽

F. Meric-Bernstam ◽

S. S. Shinde ◽

J. K. Litton ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Residual Cancer ◽

Cancer Burden ◽

Residual Cancer Burden

Abstract P1-15-25: Prognostic factors associated with pathological complete response in early breast cancer patients undergoing neoadjuvant chemotherapy. The importance of Ki-67 and molecular subtype

10.1158/1538-7445.sabcs18-p1-15-25 ◽

2019 ◽

Author(s):

BL Rapoport ◽

J Barnard-Tide ◽

T Smit ◽

S Nayler ◽

C-A Benn

Keyword(s):

Breast Cancer ◽

Prognostic Factors ◽

Cancer Patients ◽

Molecular Subtype ◽

Complete Response ◽

Breast Cancer Patients ◽

Ki 67 ◽

Factors Associated

Diffuse optical tomography changes correlate with residual cancer burden after neoadjuvant chemotherapy in breast cancer patients

Breast Cancer Research and Treatment ◽

10.1007/s10549-017-4150-7 ◽

2017 ◽

Vol 162 (3) ◽

pp. 533-540 ◽

Cited By ~ 5

Author(s):

Emerson A. Lim ◽

Jacqueline E. Gunther ◽

Hyun K. Kim ◽

Molly Flexman ◽

Hanina Hibshoosh ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Optical Tomography ◽

Diffuse Optical Tomography ◽

Breast Cancer Patients ◽

Residual Cancer ◽

Cancer Burden ◽

Residual Cancer Burden

Abstract GS6-04: The EndoPredict score predicts residual cancer burden after neoadjuvant chemotherapy and after neoendocrince therapy in HR+/HER2- breast cancer patients from ABCSG 34

10.1158/1538-7445.sabcs17-gs6-04 ◽

2018 ◽

Cited By ~ 1

Author(s):

PC Dubsky ◽

C Fesl ◽

CF Singer ◽

G Pfeiler ◽

R Kronenwett ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Residual Cancer ◽

Cancer Burden ◽

Residual Cancer Burden ◽

Her2 Breast Cancer

Tumor histological subtyping determined by hormone receptors and HER2 status defines different pathological complete response and outcome to dose-dense neoadjuvant chemotherapy in breast cancer patients

Clinical & Translational Oncology ◽

10.1007/s12094-013-1116-z ◽

2013 ◽

Vol 16 (6) ◽

pp. 548-554 ◽

Cited By ~ 6

Author(s):

A. Sánchez-Muñoz ◽

Y. Plata-Fernández ◽

M. Fernández ◽

A. Jaén-Morago ◽

M. Fernández-Navarro ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Hormone Receptors ◽

Complete Response ◽

Her2 Status ◽

Breast Cancer Patients ◽

Dose Dense

Comparison of residual cancer burden, American Joint Committee on Cancer staging and pathologic complete response in breast cancer after neoadjuvant chemotherapy: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

Breast Cancer Research and Treatment ◽

10.1007/s10549-017-4303-8 ◽

2017 ◽

Vol 165 (1) ◽

pp. 181-191 ◽

Cited By ~ 21

Author(s):

Jeffrey I. Campbell ◽

Christina Yau ◽

Polina Krass ◽

Dan Moore ◽

Lisa A. Carey ◽

...

Keyword(s):

Breast Cancer ◽

Pathologic Complete Response ◽

Complete Response ◽

Cancer Staging ◽

Residual Cancer ◽

Cancer Burden ◽

Residual Cancer Burden ◽

American Joint Committee

254P Different patterns of distant recurrence depending on the expression of hormone receptor in breast cancer patients with pathological complete response to neoadjuvant chemotherapy

Annals of Oncology ◽

10.1016/j.annonc.2020.08.063 ◽

2020 ◽

Vol 31 ◽

pp. S341

Author(s):

J. Ponce ◽

A. Rodriguez-Lescure ◽

S. Delgado ◽

H. Ballester ◽

M. Pastor-Valero ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Hormone Receptor ◽

Response To Neoadjuvant Chemotherapy

Complete Response ◽

Distant Recurrence ◽

Breast Cancer Patients ◽

Prognostic nomograms for predicting overall and cancer-specific survival in breast cancer patients not achieving pathological complete response after neoadjuvant chemotherapy

Annals of Oncology ◽

10.1093/annonc/mdy427.001 ◽

2018 ◽

Vol 29 ◽

pp. ix8

Author(s):

J. Lai ◽

Z. Pan ◽

H. Deng ◽

J. Peng ◽

P. Chen ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Complete Response ◽

Breast Cancer Patients ◽

Cancer Specific Survival

MRI in diagnosis of pathological complete response in breast cancer patients after neoadjuvant chemotherapy

European Journal of Radiology ◽

10.1016/j.ejrad.2014.11.029 ◽

2015 ◽

Vol 84 (2) ◽

pp. 242-249 ◽

Cited By ~ 4

Author(s):

Yan-Ling Li ◽

Xiao-Peng Zhang ◽

Jie Li ◽

Kun Cao ◽

Yong Cui ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Complete Response ◽

Breast Cancer Patients